Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Szukaj
Our Approach
We are driven by the desire to improve human and animal health -– now and in the future. Therefore, we have developed our framework: Sustainable Development – For Generations.
Research Beyond Borders overview
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Guardians for health
sA global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guideline.
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Championing novel science
Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
„Going beyond” Jak lekarze weterynarii przekraczają granice
„Going beyond” Jak lekarze weterynarii przekraczają granice
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Antibody therapeutics business partnering PetMedix
Combining PetMedix’ expertise in veterinary biotherapeutic technology with Boehringer Ingelheim’s long experience and innovation in human antibody discovery and development provides a unique opportunity for the partners.
Supporting grooms in equestrian sports
Find out how one organization can change the lives of those who dedicate their careers to horse care.
Spesolimab - pozytywna opinia zalecająca zatwierdzenie nowych i rozszerzonych wskazań.
Spesolimab - pozytywna opinia zalecająca zatwierdzenie nowych i rozszerzonych wskazań.
Research Beyond Borders Partnering
Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Kodeks postępowania dostawców
BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements.
2023_06_16_BI_PL_Methodological note_PAGs.2022
OWU PL-EN BI GBS Wro 2024
2023 06 BI English methodological note
2024_01_31_BI_PL_Methodological note_PAGs.2023
Informacja o przetwarzaniu danych osobowych przez Boehringer Ingelheim Sp. z o.o. w związku ze współpracą z Partnerami Biznesowymi
Informacja o przetwarzaniu danych osobowych przez Boehringer Ingelheim Sp. z o.o. w związku z współpracą z Partnerami Biznesowymi
Praxbind ChPL
Praxbind_Ulotka
Co robią różne instytucje dla bezpieczeństwa pacjentów?
Ujawnienie informacji wymaganych przez EFPIA
Przejrzystość jest podstawowym fundamentem zaufania w branży medycznej
Submit Your Opportunity
Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team